BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Myriad Genetics, Inc. 

320 Wakara Way

Salt Lake City  Utah  84108  U.S.A.
Phone: 801-584-3600 Fax: 801-584-3640


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Myriad Genetics (MYGN) Validates Active Surveillance Threshold With Prolaris For Men With Prostate Cancer 5/15/2015 8:46:43 AM
Myriad Genetics (MYGN) Showcases Its Pioneering Research At The 2015 ASCO Annual Meeting 5/14/2015 1:39:50 PM
Myriad Genetics (MYGN) To Present New Clinical Data On Prolaris At The American Urological Association 2015 Annual Meeting 5/7/2015 9:33:12 AM
Myriad Genetics (MYGN) Reports Fiscal Third-Quarter 2015 Financial Results 5/6/2015 8:47:41 AM
Here Are Some Mounting Challenges Myriad Genetics (MYGN) is Facing 5/5/2015 6:44:06 AM
Myriad Genetics, Inc. (MYGN) Launches Digital Media Campaign To Help Raise Awareness About The Role Of Companion Diagnostics In Personalized Medicine 5/4/2015 11:20:26 AM
Myriad Genetics, Inc. (MYGN) To Announce Fiscal Third Quarter 2015 Financial Results On May 5, 2015 4/22/2015 1:55:12 PM
Myriad Genetics, Inc. (MYGN) And AstraZeneca PLC (AZN) Expand Research Collaboration On Lynparza 4/1/2015 6:37:42 AM
Myriad Genetics, Inc. (MYGN) Announces Prolaris Test Biopsy Results From EMPATHY-P Study At European Association Of Urology Annual Meeting 3/20/2015 7:45:14 AM
Myriad Genetics, Inc. (MYGN) And BioMarin (BMRN) Expand Collaboration To Evaluate Mychoice HRD As A Companion Diagnostic For Talazoparib 3/17/2015 7:45:05 AM
12345678910...